The present study aims to investigate the effect of Lactobacillus casei on lipid metabolism and intestinal microflora in patients with alcoholic liver injury.
In a double-blind randomized controlled trial, 158 recruited alcoholic liver injury patients were randomized to three treatments for 60 days: low-dose group (LP, n = 58, 100 ml of Lactobacillus casei strain Shirota (LcS)), high-dose group (HP, n = 54, 200 ml of LcS), and positive control group (PC, n = 46, 100 ml of special drinks without active Lactobacillus casei). Another group of 20 healthy people was served as normal control group (NC).
The serum levels of TG and LDLC in the HP group were significantly decreased by 26.56% and 23.83%, respectively than those in the PC group (P < 0.05). After supplementation of Lactobacillus casei, there was a significant increase in the amount of Lactobacillus and Bifidobacterium when compared with the PC group (P < 0.05).
Supplementation of Lactobacillus casei can improve lipid metabolism and regulate intestinal flora disorders in patients with alcoholic liver injury.
This is a preview of subscription content, access via your institution
Subscribe to Journal
Get full journal access for 1 year
only $9.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Dunn W, Shah VH. Pathogenesis of Alcoholic Liver Disease. Clin Liver Dis. 2016;20:445–56.
Osna NA, Donohue TM, Kharbanda KK. Alcoholic liver disease: pathogenesis and current management. Alcohol Res Curr Rev. 2017;38:147.
Mathurin P, Bataller R. Trends in the management and burden of alcoholic liver disease. J Hepatol. 2015;62:S38–S46.
Felix S, Christian D, Jochen H, Ramon B. Pathophysiology and management of alcoholic liver disease: update 2016. Gut Liver. 2017;11:173–88.
Wang FS, Fan JG, Zhang Z, Gao B, Wang HY. The global burden of liver disease: the major impact of China. Hepatology. 2014;60:2099–108.
Ge N, Liang H, Liu Y, Ma AG, Han L. Protective effect of Aplysin on hepatic injury in ethanol-treated rats. Food Chem Toxicol. 2013;62:361–72.
MD Z. Abstinence: the best way to control alcoholic liver diseases. Chin J Hepatol. 2003.
Szabo G. Gut-liver axis in alcoholic liver disease. Gastroenterology. 2015;148:30–6.
Mcc C, Nl L, Cm F, Jl G, D A, C G, et al. Comparing the effects of acute alcohol consumption in germ-free and conventional mice: the role of the gut microbiota. BMC Microbiol. 2014;14:240.
Liu Y, Zhang J, Gao SL, Li TJ, Liang H. Quantitative analysis of gut flora in patients with alcoholic liver disease. Acta Nutrimenta Sin. 2018;40:36–41.
LI TJ, Zhang YJ, Wang ZL, Liu Y, Liang H. Protective Effect of Lactobacillus casei on Acrylamide-Induced Intestinal Injury in Rats. Food Science. 2018;39(9):128–33.
Zhang YH, Cong WH, Liu JX. Effect of crocin on mitochondrial dynamics in SH-SY5Y cells against injury induced by oxygen-glucose deprivation. Chinese Pharmacol. Bull. 2016;32:986–91.
Liang ZY, Liu Y, Xue ML, Liu J, Liang H. Inhibitory effect and immunological mechanism of Lactobacillus casei on induction of breast cancer by 7,12-dimethylbenz(a)anthracene in rats. Carcinog, Teratog Mutagen. 2017;029:7–12.
Wu YY, Dou M, Ma AG, Liu Y, Liang H. Effect of Lactobacillus casei on behavior and intestinal flora in rats with depression. Acta Acad Med Qingdao Univ. 2017;53:163–7.
Arora S, Kaur IP, Chopra K, Rishi P. Efficiency of double layered microencapsulated probiotic to modulate proinflammatory molecular markers for the management of alcoholic liver disease. Mediators Inflamm. 2014;2014:715130.
Ritze Y, Bárdos G, Claus A, Ehrmann V, Bergheim I, Schwiertz A, et al. Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice. PloS ONE. 2014;9:e80169.
Chang B, Sang L, Wang Y, Tong J, Zhang D, Wang B. The protective effect of VSL#3 on intestinal permeability in a rat model of alcoholic intestinal injury. BMC Gastroenterol. 2013;13:151.
Kim WG, Kim HI, Kwon EK, Han MJ, Kim DH. Lactobacillus plantarum LC27 and Bifidobacterium longum LC67 mitigate alcoholic steatosis in mice by inhibiting LPS-mediated NF-κB activation through restoration of the disturbed gut microbiota. Food Funct. 2018;9:4255–65.
Organization WH. Global Status Report on Alcohol And Health: World Health Organization, Geneva (Switzerland); 2014.
Tang YL, Xiang XJ, Wang XY, Cubells JF, Babor TF, Hao W. Alcohol and alcohol-related harm in China: policy changes needed. Bull World Health Organ. 2013;91:270–6.
National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology, Chinese Medical Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association. [Guidelines of prevention and treatment for alcoholic liver disease: a 2018 update]. Zhonghua Gan Zang Bing Za Zhi. 2018;26:188–94.
Zhang XS, Liu YH, Zhang Y, Xu Q, Liu Z, Yang XY, et al. probiotics supplementation on respiratory infection and body immune function of soldiers in military training. Acad J Chin PLA Med Sch. 2018;39:54–8.
Matsumoto K, Takada T, Shimizu K, Moriyama K, Kawakami K, Hirano K, et al. Effects of a probiotic fermented milk beverage containing Lactobacillus casei strain Shirota on defecation frequency, intestinal microbiota, and the intestinal environment of healthy individuals with soft stools. J Biosci Bioeng. 2010;110:547–52.
Matsumoto K, Takada T, Shimizu K, Kado Y, Kawakami K, Makino I, et al. The effects of a probiotic milk product containing lactobacillus casei strain shirota on the defecation frequency and the intestinal microflora of sub-optimal health state volunteers: a randomized placebo-controlled cross-over study. Bioence Microbiota Food Health. 2006;25:39–48.
Li XS, Liu JZ, Li SF. Effect of Jiedu Qinggan decoction combined with reduced glutathione in treating alcoholic hepatitis. Chinese J Integr Tradit West Med Dig. 2012;20:52–5.
Kirpich IA, Solovieva NV, Leikhter SN, Shidakova NA, Lebedeva OV, Sidorov PI, et al. Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study. Alcohol. 2008;42:675–82.
Kondrup J, Allison SP, Elia M, Vellas B. § MP. ESPEN guidelines for nutrition screening 2002. Clin Nutr. 2003;22:415–21.
Federico A, Dallio M, Caprio GG, Ormando VM, Loguercio C. Gut microbiota and the liver. Minerva Gastroenterol Dietol. 2017;63:385–98.
Hartmann P, Hochrath K, Horvath A, Chen P, Seebauer CT, Llorente C, et al. Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice. Hepatology. 2018;67:2150–66.
Inokuchi S, Tsukamoto H, Park E, Liu ZX, Brenner DA, Seki E. Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice. Alcohol Clin Exp Res. 2011;35:1509–18.
Mazagova M, Wang L, Anfora AT, Wissmueller M, Lesley SA, Miyamoto Y, et al. Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice. FASEB J. 2015;29:1043–55.
Wang WJ, Xiao P, Xu HQ, Niu JQ, Gao YH. Hepatology do. Growing burden of alcoholic liver disease in China: a review. World J Gastroenterol. 2019;25:1445–56.
Han SH, Suk KT, Kim DJ, Kim MY, Baik SK, Kim YD, et al. Effects of probiotics (cultured Lactobacillus subtilis/Streptococcus faecium) in the treatment of alcoholic hepatitis: randomized-controlled multicenter study. Eur J Gastroenterol Hepatol. 2015;27:1300–6.
Barone R, Rappa F, Macaluso F, Caruso Bavisotto C, Sangiorgi C, Di Paola G, et al. Alcoholic liver disease: a mouse model reveals protection by Lactobacillus fermentum. Clin Transl Gastroenterol. 2016;7:e138.
Albano E. Oxidative mechanisms in the pathogenesis of alcoholic liver disease. Mol Asp Med. 2008;29:9–16.
Kohn G, Wong HR, Bshesh K, Zhao B, Vasi N, Denenberg A, et al. Heat shock inhibits tnf-induced ICAM-1 expression in human endothelial cells via I kappa kinase inhibition. Shock. 2002;17:91–7.
McClain CJ, Hill DB, Song Z, Chawla R, Watson WH, Chen T, et al. S-Adenosylmethionine, cytokines, and alcoholic liver disease. Alcohol. 2002;27:185–92.
Szabo Gyongyi. Alcoholic liver disease and the gut-liver axis. World J Gastroenterol. 2010;16:1321.
Bull-Otterson L, Feng W, Kirpich I, Wang Y, Qin X, Liu Y, et al. Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment. PLoS ONE. 2013;8:e53028.
Colborn JM, Byrd BD, Koita OA, Krogstad DJ. Estimation of copy number using SYBR Green: confounding by AT-rich DNA and by variation in amplicon length. Am J Trop Med Hyg. 2008;79:887–92.
Ma Y, Li R, Liu Y, Liu M, Liang H. Protective Effect of Aplysin Supplementation on Intestinal Permeability and Microbiota in Rats Treated with Ethanol and Iron. Nutrients. 2018;10:681.
Shen TD, Pyrsopoulos N, Rustgi VK. Microbiota and the liver. Liver Transplant.2018;24:539–50.
Frosali S, Pagliari D. How the intricate interaction among toll-like receptors, microbiota, and intestinal immunity can influence gastrointestinal. Pathology. 2015;2015:489821.
Chen P, Torralba M, Tan J, Embree M, Zengler K, Stärkel P, et al. Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice. Gastroenterology. 2015;148:203–14.e16.
McClain CJ, Barve SS, Barve A, Marsano L. Alcoholic liver disease and malnutrition. Alcohol Clin Exp Res. 2011;35:815–20.
Huang XY, Li GP, Kou JG, Li L, Xia XM, Yang L, et al. Relationship between intestinal dysbacteriosis and Child-Pugh classification in patients with cirrhosis. J Clin Hepatol. 2015;31:392–5.
Chen QX, Zhu JL, Xu Y. Effect of probiotics on nutritional status, inflammatory reaction and chemotherapy-related complications in patients having undergone chemotherapeutic treatment of colorectal cancer. Health Res. 2020;40:68–71.
Zhang L, Sun YS, He TZ. Effects of viable Tri-Bifidobacteria on inflammatory factors, immunity and nutritional status of patients with gastric cancer after partial resection. Chin J Microecol. 2019;31:680–3.
Liang H, Lyu R, Fu Y, Zhou ZT, Liu Y, Zhou XB, et al. Effects of probiotics on alcoholic liver injury in rats and its mechanisms. Chinese Pharmacol Bull. 2016;32:991–7.
Marsano LS, Mendez C, Hill D, Barve S, Mcclain CJ. Diagnosis and treatment of alcoholic liver disease and its complications. Alcohol Res. 2003;27:247–56.
This work was funded and supported by National Natural Science Foundation of China (Grant Nos. 81573137 and 81872605).
Conflict of interest
The authors declare that they have no conflict of interest.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Li, X., Liu, Y., Guo, X. et al. Effect of Lactobacillus casei on lipid metabolism and intestinal microflora in patients with alcoholic liver injury. Eur J Clin Nutr 75, 1227–1236 (2021). https://doi.org/10.1038/s41430-020-00852-8
This article is cited by
Compound Probiotic Ameliorates Acute Alcoholic Liver Disease in Mice by Modulating Gut Microbiota and Maintaining Intestinal Barrier
Probiotics and Antimicrobial Proteins (2022)
Intestinal Microbiomics and Metabolomics Insights into the Hepatoprotective Effects of Lactobacillus paracasei CCFM1222 Against the Acute Liver Injury in Mice
Probiotics and Antimicrobial Proteins (2022)